Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-02T19:05:59.345Z.
Calculation as of: 2026-10-02T19:05:59.345Z.
Quote observation: 2026-10-02T19:05:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a42e17afc1a1b5c0c05c4bcc318afc1e85bdb01f5d7a677422ba224d703768eb
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Recursion Pharmaceuticals, Inc.
Market Cap
$2.13B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.49B
EV/FCF Ratio
N/A
TTM Avg
44.45x
3Y Avg
44.45x
5Y Avg
44.45x
Market Cap
$1.74B
EV/FCF Ratio
26.63x
TTM Avg
43.79x
3Y Avg
32.56x
5Y Avg
29.02x
Market Cap
$1.71B
EV/FCF Ratio
N/A
TTM Avg
6.04x
3Y Avg
6.04x
5Y Avg
6.04x
Market Cap
$2.72B
EV/FCF Ratio
39.39x
TTM Avg
57.66x
3Y Avg
90.43x
5Y Avg
90.43x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. (RXRX) | $2.13B | N/A | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | N/A | 44.45x | 44.45x | 44.45x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 26.63x | 43.79x | 32.56x | 29.02x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | N/A | 6.04x | 6.04x | 6.04x |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 39.39x | 57.66x | 90.43x | 90.43x |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | 5.64x | 6.84x | 8.42x | 16.00x |
| NeoGenomics, Inc. (NEO)vs › | $470.35M | N/A | 51.06x | 46.23x | 33.62x |
| NRC Health (NRC)vs › | $459.30M | 25.23x | 33.00x | 32.11x | 32.13x |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
